-

Piper Sandler Strengthens Private Capital Advisory Team with Addition of Andy Nick as Co-Head of Secondary Capital Advisory

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Andy Nick as managing director and co-head of secondary capital advisory within the private capital advisory group. Nick will work closely with private equity clients to provide bespoke liquidity and capital solutions, including GP-led continuation funds, fund recapitalizations, and LP portfolio transactions.

“Andy is a highly respected advisor with deep relationships across the private equity ecosystem and has a strong track record of delivering thoughtful, strategic secondary solutions. His addition reflects our continued investment in the private markets and enhances our ability to serve clients across the full lifecycle of fund management, specifically as it relates to our GP continuation vehicle capabilities,” said Ryan Schlitt, global head of private capital advisory at Piper Sandler.

Nick brings over 20 years of experience in private capital markets, with a focus on advising general partners, limited partners, and institutional investors on complex secondary transactions. He joins the firm from Jefferies, where he was a managing director and played a key role in the founding and growth of the firm’s secondary advisory practice. Previously, he held senior roles at Greenhill and Cogent Partners. Nick began his investment banking career at Citigroup after earning a bachelor’s degree from Baylor University and a Master of Business Administration from Harvard Business School.

“I’m thrilled to join Piper Sandler to help grow the firm’s secondary advisory capabilities. The firm’s collaborative culture and commitment to private markets make it a compelling platform for delivering high-impact solutions to fund sponsors and investors,” said Nick.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2025. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Versions
$Cashtags

Contacts

Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

Social Media Profiles
More News From Piper Sandler Companies

Piper Sandler Appoints Aamer Naseer to Head of Life Sciences Outsourcing and B2B Med Tech

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2B med tech. “Aamer has built deep relationships across the life sciences ecosystem and has a strong track record of advising private equity firms, public companies and founders/entrepreneurs. His leadership, sector expertise and commitment to our clients position us exceptionally well to continue e...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Jason Arnold

MINNEAPOLIS & LONDON--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Jason Arnold as a managing director in the healthcare investment banking group. Arnold will be initially based in London while serving clients globally. He will be advising life science tools and diagnostic companies on mergers and acquisitions, strategic partnerships and capital raising transactions. “We’re delighted to welcome Jason to the healthcare i...
Back to Newsroom